J Neurophysiol (May 1, 2003). 10.1152/jn.00095.2003
CORRIGENDUM
Volume 88, December 2002
Pages 3032-3045: Chau C, Giroux N, Barbeau H, Jordan L, and
Rossignol S, "Effects of Intrathecal Glutamatergic Drugs on
Locomotion. I. NMDA in Short-Term Spinal Cats"
(10.1152/jn.00138.2002;
http://jn.physiology.org/cgi/content/full/88/6/3032). Figure
4 was published at very low resolution. A
new version is printed here, along with the original legend.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
The effects of NMDA on locomotion during the intermediate phase (7 days
postspinalization). A: stick diagram (1 step cycle) and
averaged EMG of hindlimb flexors (Srt, St) and extensors (GL, GM)
synchronized to LSt during treadmill locomotion (0.4 m/s) before any
drug injection. A shaded bar was placed under the stick diagram
representing the onset of the stance phase; cat NG2. B:
locomotion recorded at 17 min after NMDA (1 mM it). Note the marked
increase in step cycle duration as well as the marked increase in
flexor and extensor muscle activities. C: locomotion at
24 h after NMDA injection. Note the decrease in the muscle
activities in RSrt and RVL. D: locomotion at 72 h
after NMDA injection, a further deterioration in the muscle activities
was seen.
|
|